Why Bo Wiinberg Is Joining Advanced Therapies Europe 2026

“Right now, Europe is too fragmented. We need to figure out how to succeed as one ecosystem.”

Before joining us at Advanced Therapies Europe 2026, Bo Wiinberg, CBO at Novo Nordisk Foundation Cellerator, explains why Europe must come together to unlock the full potential of advanced therapies.

Join Bo and 600 senior leaders from biotech, pharma, investment, manufacturing, healthcare and technology organisations for three days of high-value networking, strategic discussions and practical insights designed to help move the industry forward.
 

Apply to Attend  View the Full Agenda

Europe is at a defining moment in advanced therapies.

The science is proven. The pipeline is maturing. But commercial success remains the hardest part.

Fragmented regulation, inconsistent market access, and reimbursement complexity are holding the continent back. Not for lack of innovation, but lack of alignment.

Advanced Therapies Europe exists to change that.

Three days. The leaders, investors, and innovators who are actually moving the needle. Targeted content, curated networking, and high-value connections. Built specifically for the European CGT landscape.
 

Apply to attend View the Agenda